@article{a1bc85859ed44383aad8777b1da3b652,
title = "Competitive sport participation among athletes with heart disease: A call for a paradigm shift in decision making",
keywords = "Athletes, Cardiac, Death, Decision making, Genetic heart diseases, Return to sport, Sudden",
author = "Baggish, {Aaron L.} and Ackerman, {Michael J.} and Rachel Lampert",
note = "Funding Information: Dr Baggish has no relevant disclosures. Dr Ackerman is a consultant for Audentes Therapeutics (modest), Boston Scientific (modest), Gilead Sciences (modest), Invitae (modest), Medtronic (modest), MyoKardia (modest), and St. Jude Medical (modest). Dr Ackerman and Mayo Clinic have an equity/ royalty-based licensing agreement with AliveCor (modest), Blue Ox Health (modest), and StemoniX (modest). Dr Lampert has received significant research grants from Medtronic Inc, St Jude/Abbott, and Boston Scientific, and has received honoraria and serves on an advisory board for Medtronic (modest",
year = "2017",
doi = "10.1161/CIRCULATIONAHA.117.029639",
language = "English (US)",
volume = "136",
pages = "1569--1571",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "17",
}